CLRB•benzinga•
Cellectar Announces Publication Of Data from Its Expansion Cohort of the Phase II CLOVER-1 Study Iopofosine I-131 In Relapsed/Refractory Multiple Myeloma In Nature's Blood Cancer Journal
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 13, 2022 by benzinga